Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. (2021)
Attributed to:
Expansion of the Metabolomic and Cardiovascular Disease Facility at Cambridge University
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.66020
Publication URI: https://www.repository.cam.ac.uk/handle/1810/318904
Type: Journal Article/Review